{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:28:48Z","timestamp":1774078128571,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Latent infection with Mycobacterium tuberculosis is defined by a positive IFN-\u03b3 release assay (IGRA) result in the absence of active tuberculosis. Only few, mostly monocentric studies have evaluated the role of IGRAs to predict the development of tuberculosis in recent contacts in low-incidence countries of tuberculosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To analyze IGRA results and the effect of preventive chemotherapy on tuberculosis progression rates among recent contacts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Results from contact investigations at 26 centers in 10 European countries including testing for latent infection with M. tuberculosis by the QuantiFERON-TB Gold In-Tube (QFT) test or the T-SPOT.TB (TSPOT) were prospectively collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Among 5,020 contacts of 1,023 index cases, 25 prevalent secondary cases were identified at screening. Twenty-four incident cases occurred among 4,513 contacts during 12,326 years of cumulative follow-up. In those with a positive IGRA result, tuberculosis incidence was 0.2 (QFT) and 0 (TSPOT) per 100 patient-years when contacts received preventive chemotherapy versus 1.2 (QFT) and 0.8 (TSPOT) per 100 patient-years in those not treated (38 and 37 patients needed to be treated to prevent one case, respectively). Positive and negative predictive values were 1.9% (95% confidence interval [CI], 1.1\u20133.0) and 99.9% (95% CI, 99.7\u2013100) for the QFT and 0.7% (95% CI, 0.1\u20132.6) and 99.7% (95% CI, 99.1\u201399.9) for the TSPOT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tuberculosis rarely developed among contacts, and preventive chemotherapy effectively reduced the tuberculosis risk among IGRA-positive contacts. Although the negative predictive value of IGRAs is high, the risk for the development of tuberculosis is poorly predicted by these assays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201502-0232oc","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T15:14:44Z","timestamp":1426173284000},"page":"1176-1184","source":"Crossref","is-referenced-by-count":100,"title":["Risk Assessment of Tuberculosis in Contacts by IFN-\u03b3 Release Assays. A Tuberculosis Network European Trials Group Study"],"prefix":"10.1093","volume":"191","author":[{"given":"Jean-Pierre","family":"Zellweger","sequence":"first","affiliation":[{"name":"Swiss Lung Association, Berne, Switzerland"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[{"name":"Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari-Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy"}]},{"given":"Michael","family":"Block","sequence":"additional","affiliation":[{"name":"Division of Clinical Infectious Diseases, Medical Clinic, Research Center Borstel, Borstel, Germany"}]},{"given":"Simone","family":"Dore","sequence":"additional","affiliation":[{"name":"Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari-Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy"}]},{"given":"Neus","family":"Altet","sequence":"additional","affiliation":[{"name":"Unitat de Tuberculosis Vall d\u2019Hebron-Drassanes, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Catalan Health Institute and Primary Healthcare University Research Institut-IDIAP Jordi Gol, Barcelona, Spain"}]},{"given":"Rebecca","family":"Blunschi","sequence":"additional","affiliation":[{"name":"Swiss Lung Association, Z\u00fcrich, Switzerland"}]},{"given":"Matthias","family":"Bogyi","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Medicine, Wilhelminenspital, Vienna, Austria"}]},{"given":"Graham","family":"Bothamley","sequence":"additional","affiliation":[{"name":"Homerton University Hospital, London, United Kingdom"}]},{"given":"Christina","family":"Bothe","sequence":"additional","affiliation":[{"name":"Public Health Service Braunschweig, Braunschweig, Germany"}]},{"given":"Luigi","family":"Codecasa","sequence":"additional","affiliation":[{"name":"Regional TB Reference Centre, Villa Marelli Institute, Niguarda Ca'Granda Hospital, Milan, Italy"}]},{"given":"Patrizia","family":"Costa","sequence":"additional","affiliation":[{"name":"Swiss Lung Association Ticino, Lugano, Switzerland"}]},{"given":"Jose","family":"Dominguez","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, Institut d\u2019Investigaci\u00f3 en Ci\u00e8ncies de la Salut Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Ciber Enfermedades Respiratorias, Instituto de Salud Carlos III, Badalona, Spain"}]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Vila Nova de Gaia\/Espinho, Portuguese Reference Centre for M\/XDR-TB, Vila Nova de Gaia, Portugal"},{"name":"Department of Clinical Epidemiology, Predictive Medicine and Public Health, Institute of Public Health, University of Porto, Porto, Portugal"}]},{"given":"Andreas","family":"Fl\u00f8e","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark"}]},{"given":"Isabelle","family":"Fresard","sequence":"additional","affiliation":[{"name":"Centre Antituberculeux, Geneva, Switzerland"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[{"name":"S. Neumolog\u00eda, Hospital San Agust\u00edn, Avil\u00e9s, Asturias, Spain"}]},{"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[{"name":"Translational Research Unit, Department of Epidemiology and Preclinical Research, \u201cL. Spallanzani\u201d National Institute for Infectious Diseases, Rome, Italy"}]},{"given":"Petra","family":"Halm","sequence":"additional","affiliation":[{"name":"Public Health Service Wilhelmshaven, Wilhelmshaven, Germany"}]},{"given":"Doris","family":"Hellwig","sequence":"additional","affiliation":[{"name":"Public Health Service G\u00f6ttingen, G\u00f6ttingen, Germany"}]},{"given":"Eveline","family":"Henninger","sequence":"additional","affiliation":[{"name":"Swiss Lung Association Fribourg, Fribourg, Switzerland"}]},{"given":"Helga","family":"Heykes-Uden","sequence":"additional","affiliation":[{"name":"Public Health Service Hannover, Hannover, Germany"}]},{"given":"Liane","family":"Horn","sequence":"additional","affiliation":[{"name":"Swiss Lung Association St. Gallen, St. Gallen, Switzerland"}]},{"given":"Katarzyna","family":"Kruczak","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Department of Medicine, Cracow, Poland"}]},{"given":"Irene","family":"Latorre","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, Institut d\u2019Investigaci\u00f3 en Ci\u00e8ncies de la Salut Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Ciber Enfermedades Respiratorias, Instituto de Salud Carlos III, Badalona, Spain"}]},{"given":"Genevi\u00e8ve","family":"Pache","sequence":"additional","affiliation":[{"name":"Swiss Lung Association Vaud, Lausanne, Switzerland"}]},{"given":"Heidrun","family":"Rath","sequence":"additional","affiliation":[{"name":"Public Health Service L\u00fcbeck, L\u00fcbeck, Germany"}]},{"given":"Felix C.","family":"Ringshausen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany"}]},{"given":"Asunci\u00f3n Seminario","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Unitat de Tuberculosis Vall d\u2019Hebron-Drassanes, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"}]},{"given":"Ivan","family":"Solovic","sequence":"additional","affiliation":[{"name":"Catholic University, Ruzomberok, Slovakia"}]},{"given":"Maria-Luiza de","family":"Souza-Galv\u00e3o","sequence":"additional","affiliation":[{"name":"Unitat de Tuberculosis Vall d\u2019Hebron-Drassanes, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"}]},{"given":"Ursula","family":"Widmer","sequence":"additional","affiliation":[{"name":"Swiss Lung Association Aargau, Aargau, Switzerland"}]},{"given":"Peter","family":"Witte","sequence":"additional","affiliation":[{"name":"Public Health Service Minden, Minden, Germany"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[{"name":"Division of Clinical Infectious Diseases, Medical Clinic, Research Center Borstel, Borstel, Germany"},{"name":"International Health\/Infectious Diseases, University of L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"Tuberculosis Unit, German Center for Infection Research, Borstel, Germany"},{"name":"Department of Medicine, University of Namibia School of Medicine, Windhoek, Namibia; and"},{"name":"Department of Medicine, Karolinska Institute, Stockholm, Sweden"}]}],"member":"286","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"2026032100200370300_bib1","volume-title":"Guidelines on the management of latent tuberculosis infection","author":"World Health Organization","year":"2014"},{"key":"2026032100200370300_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1183\/09031936.00011708","article-title":"Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey","volume":"32","author":"Bothamley","year":"2008","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1183\/09031936.00201609","article-title":"Tuberculosis contact investigation in low prevalence countries: a European consensus","volume":"36","author":"Erkens","year":"2010","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib5","first-page":"1370","article-title":"Die Allergieprobe zur Diagnose der Tuberkulose im Kindesalter","volume":"57","author":"von Pirquet","year":"1907","journal-title":"Wien Med Wochenschr"},{"issue":"12","key":"2026032100200370300_bib6","first-page":"402","article-title":"Die von Pirquetsche Hautreaktion und die intraven\u00f6se Tuberkulinbehandlung","author":"Mendel","year":"1908","journal-title":"Med Klin"},{"issue":"2","key":"2026032100200370300_bib7","first-page":"10","article-title":"L'intradermo-reaction de la tuberculine et son interpretation clinique","author":"Mantoux","year":"1910","journal-title":"Presse Med"},{"key":"2026032100200370300_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2026032100200370300_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100200370300_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/thoraxjnl-2011-200956","article-title":"Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk","volume":"68","author":"Haldar","year":"2013","journal-title":"Thorax"},{"key":"2026032100200370300_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201406-1159OC","article-title":"Risk of tuberculosis after recent exposure: a 10-year follow-up study of contacts in Amsterdam","volume":"190","author":"Sloot","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100200370300_bib12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1183\/09031936.00187112","article-title":"How can we achieve better prevention of progression to tuberculosis among contacts?","volume":"42","author":"Geis","year":"2013","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1556\/EuJMI.2.2012.4.4","article-title":"TBNET - Collaborative research on tuberculosis in Europe","volume":"2","author":"Giehl","year":"2012","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"2026032100200370300_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100200370300_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-\u03b3 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100200370300_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","article-title":"Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers","volume":"188","author":"Slater","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100200370300_bib17","doi-asserted-by":"crossref","first-page":"e112681","DOI":"10.1371\/journal.pone.0112681","article-title":"Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany","volume":"9","author":"Gutsfeld","year":"2014","journal-title":"PLoS ONE"},{"key":"2026032100200370300_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"Diel","year":"2007","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(08)70071-9","article-title":"Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Morrison","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"2026032100200370300_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis","volume":"41","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1183\/09031936.00183812","article-title":"Risk of tuberculosis among contacts in a low-incidence setting","volume":"41","author":"Dobler","year":"2013","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.00164612","article-title":"Contact screening in tuberculosis: can we identify those with higher risk?","volume":"41","author":"Mendes","year":"2013","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/cis029","article-title":"Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City","volume":"54","author":"Anger","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026032100200370300_bib24","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1164\/ajrccm.162.6.2004022","article-title":"Outcomes of contact investigations of infectious tuberculosis patients","volume":"162","author":"Marks","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100200370300_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/cir321","article-title":"Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics","volume":"53","author":"Mancuso","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026032100200370300_bib26","first-page":"820","article-title":"Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis","volume":"13","author":"Kik","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032100200370300_bib27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon \u03b3 release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2013","journal-title":"Thorax"},{"key":"2026032100200370300_bib28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1183\/09031936.00089510","article-title":"Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis","volume":"37","author":"Lee","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"Comstock","year":"1974","journal-title":"Am J Epidemiol"},{"key":"2026032100200370300_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2026032100200370300_bib31","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis: a general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"key":"2026032100200370300_bib32","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"Landry","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032100200370300_bib33","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1183\/09031936.00079310","article-title":"Treatment of latent infection with Mycobacterium tuberculosis: update 2010","volume":"37","author":"Leung","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032100200370300_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.140099","article-title":"Performance of the tuberculin skin test and interferon-\u03b3 release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches","volume":"91","author":"Goletti","year":"2014","journal-title":"J Rheumatol Suppl"},{"key":"2026032100200370300_bib35","first-page":"99","article-title":"Anwendung und Akzeptanz der pr\u00e4ventiven Behandlung bei Kindern mit Kontakt zu Tuberkulose-Erkrankten","volume-title":"Epidemiol Bull","author":"Robert-Koch-Institut","year":"2013"},{"key":"2026032100200370300_bib36","doi-asserted-by":"crossref","first-page":"w13860","DOI":"10.4414\/smw.2013.13860","article-title":"High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton","volume":"143","author":"Sarivalasis","year":"2013","journal-title":"Swiss Med Wkly"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/10\/1176\/67285067\/ajrccm_191_10_1176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/10\/1176\/67285067\/ajrccm_191_10_1176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:20:11Z","timestamp":1774066811000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/191\/10\/1176\/8504914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,5,15]]},"published-print":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201502-0232oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,5]]}}}